The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
Prognostic markers for glioblastoma multiforme (GBM) are important for patient management. Recent advances have identified prognostic markers for GBMs that use telomerase or the alternative lengthening of telomeres (ALT) mechanism for telomere maintenance. Approximately 40% of GBMs have no defined t...
Main Authors: | Janice A Royds, Shafagh Al Nadaf, Anna K Wiles, Yu-Jen Chen, Antonio Ahn, Alisha Shaw, Sara Bowie, Frederic Lam, Bruce C Baguley, Antony W Braithwaite, Martin R MacFarlane, Noelyn A Hung, Tania L Slatter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3202568?pdf=render |
Similar Items
-
Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.
by: Sonal Sawhney, et al.
Published: (2015-01-01) -
Predicting the SP500 Index Trend Based on GBDT and LightGBM Methods
by: shangchen Ma
Published: (2020-01-01) -
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
by: Lucia Cottone, et al.
Published: (2020-04-01) -
Frequent aberrant DNA methylation of CDKN2A locus in capillary hemangioblastomas, pheochromocytomas and gliomas
by: Justina TVERKUVIENĖ, et al.
Published: (2011-01-01) -
Sicker and Poorer
by: Na Yin
Published: (2015-02-01)